Lanzamiento Enero 2027

Estudio2017Acceso abierto

Dietary cholesterol promotes repair of demyelinated lesions in the adult brain

Berghoff SA, Gerndt N, Winchenbach J, Stumpf SK, Hosang L, Odoardi F, Ruhwedel T, Böhler C, Barrette B, Stassart R, Liebetanz D, Dibaj P, Möbius W, Edgar JM, Saher G

Nature communications · 115 citas

Cómo se estudió

Diseño
Estudio en animales (clasificado por nuestro filtro de IA)
Estudiado en
Animales
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
Deutsche Forschungsgemeinschaft
Subvenciones
Deutsche Forschungsgemeinschaft (SA 2014/2-1)

Según 1 financiador declarado.

Publicación

Publicado
2017-01-24 · Nat Commun · vol. 8 · número 1 · pág. 14241
Editorial
Nature Portfolio
Citado
149 citas · más que el 97% de estudios similares · 10.4× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
70 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
RNA Research and Splicing · Neurogenesis and neuroplasticity mechanisms · MicroRNA in disease regulation
Palabras clave
Remyelination, Multiple sclerosis, Cholesterol, Medicine, Myelin, Demyelinating disease, Experimental autoimmune encephalomyelitis, Internal medicine, Endocrinology, Central nervous system, Immunology
MeSH
brain, oligodendroglia, axons, cells, cultured, stem cells, animals, mice, inbred c57bl, humans, mice, multiple sclerosis, encephalomyelitis, autoimmune, experimental, disease models, animal, cuprizone, cholesterol, cholesterol, dietary, myelin proteins, cell differentiation, cell proliferation, dietary supplements, male, primary cell culture, biomarkers

15 autores

  • Stefan A. Berghoff🇩🇪Max Planck Institute of Experimental Medicine
  • Nina Gerndt🇩🇪Max Planck Institute of Experimental Medicine
  • Jan Winchenbach🇩🇪Max Planck Institute of Experimental Medicine
  • Sina K. Stumpf🇩🇪Max Planck Institute of Experimental Medicine
  • Leon Hosang🇩🇪Hertie Foundation
  • Francesca Odoardi🇩🇪Hertie Foundation
  • Torben Ruhwedel🇩🇪Max Planck Institute of Experimental Medicine
  • Carolin Böhler🇩🇪Max Planck Institute of Experimental Medicine
  • Benoit Barrette🇩🇪Max Planck Institute of Experimental Medicine
  • Ruth Martha Stassart🇩🇪Max Planck Institute of Experimental Medicine; University of Göttingen
  • David Liebetanz🇩🇪University of Göttingen
  • Payam Dibaj🇩🇪Max Planck Institute of Experimental Medicine
  • Wiebke Möbius🇩🇪Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103; Max Planck Institute of Experimental Medicine
  • Julia M. Edgar🇩🇪🇨🇦🇬🇧Max Planck Institute of Experimental Medicine; Institute of Infection and Immunity; University of Glasgow
  • Gesine Saher🇩🇪 · autor de correspondenciaMax Planck Institute of Experimental Medicine

Resumen

El texto original del estudio, en el idioma en que se publicó.

Multiple Sclerosis (MS) is an inflammatory demyelinating disorder in which remyelination failure contributes to persistent disability. Cholesterol is rate-limiting for myelin biogenesis in the developing CNS; however, whether cholesterol insufficiency contributes to remyelination failure in MS, is unclear. Here, we show the relationship between cholesterol, myelination and neurological parameters in mouse models of demyelination and remyelination. In the cuprizone model, acute disease reduces serum cholesterol levels that can be restored by dietary cholesterol. Concomitant with blood-brain barrier impairment, supplemented cholesterol directly supports oligodendrocyte precursor proliferation and differentiation, and restores the balance of growth factors, creating a permissive environment for repair. This leads to attenuated axon damage, enhanced remyelination and improved motor learning. Remarkably, in experimental autoimmune encephalomyelitis, cholesterol supplementation does not exacerbate disease expression. These findings emphasize the safety of dietary cholesterol in inflammatory diseases and point to a previously unrecognized role of cholesterol in promoting repair after demyelinating episodes.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.